title: Merck launches three new trials on tulisokibart
source: Finnhub
date: 2025-10-06
url: https://finnhub.io/api/news?id=7bba01aa62a4556bd74d00b4ec4edbbf0d53c4dfe2054340a1084923dee94dda
Merck announces the launch of three Phase 2b trials evaluating the safety and efficacy of tulisokibart , an investigational humanized monoclonal antibody targeting tumor necrosis factor -like...
